Abstract:Objective: The goal of this study was to reveal the clinical manifestations of nonneutropenic invasive pulmonary aspergillosis (IPA), which are different from those of neutropenic patients. Methods: The clinical data of patients with nonneutropenic IPA were collected at the Department of Respiratory and Critical Care Medicine, Jinling Hospital, from February 2009 to November 2019. We analyzed the general conditions, clinical manifestations, imaging findings, and laboratory tests of these IPA patients. Results: A total of 116 patients with nonneutropenic IPA (31 proven and 85 probable) were included. They had an average age of 59.8 years. The most common underlying disease was chronic obstructive pulmonary disease (COPD, n = 33). The common clinical symptoms included cough (93.1%, n = 108), expectoration (59.5%, n = 69), fever (57.8%, n = 67), hemoptysis (30.2%, n = 35), and dyspnea (40.5%, n = 47). The common CT imaging manifestations included consolidation (47.4%, n = 55), cavities (47.4%, n = 55), air crescent sign (14.7%, n = 17), and nodules (8.6%, n = 10). Multiple lesions (74.1%, n = 86) were more common than single lesions (17.2%, n = 20) and diffuse lesions (8.6%, n = 10). The positive rate of laboratory tests was 88.2% (30/34) for BALF galactomannan (GM), 55.4% (56/101) for serum GM, 45.3% (48/106) for 1,3-β-D-glucan (BDG), 43.3% (46/106) for sputum culture, and 36.4% (20/55) for BALF culture. Patients who had high serum GM level [GM optical density index (ODI) >1] were more likely to have severe respiratory symptoms and higher serum ferritin. Further investigation showed that there was a positive correlation between serum GM level and serum ferritin level. Conclusion: The clinical symptoms and radiological manifestations of nonneutropenic IPA are diverse and often lead to delayed diagnosis. It is important to become more vigilant of aspergillosis in nonneutropenic patients in order to achieve early diagnosis and treatment and to reduce mortality.

Hospital-acquired Invasive Pulmonary Aspergillosis in Patients with Hepatic Failure

Epidemiology of Invasive Pulmonary Aspergillosis in Patients with Liver Failure: Clinical Presentation, Risk Factors, and Outcomes.

Invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure.

Clinical Findings in 19 Cases of Invasive Pulmonary Aspergillosis with Liver Cirrhosis

Risk Factors for Invasive Pulmonary Aspergillosis and Hospital Mortality in Acute-On-Chronic Liver Failure Patients: A Retrospective-Cohort Study

Early Diagnosis of Invasive Pulmonary Aspergillosis

Invasive Pulmonary Aspergillosis in Acute-on-Chronic Liver Failure Patients: Short-Term Outcomes and Antifungal Options

Clinical analysis of 21 cases of invasive pulmonary aspergillosis

Invasive Pulmonary Aspergillosis in Patients with HBV-Related Acute on Chronic Liver Failure

Prognostic factors and outcomes of invasive pulmonary aspergillosis, a retrospective hospital-based study

The Clinical Characteristics of Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.

Invasive Pulmonary Aspergillosis in Patients with Antineutrophil Cytoplasmic Antibody Associated Vasculitis.

Clinical and Non-Clinical Characteristics of Pulmonary Aspergillosis in Non-Neutropenic Patients

A clinical study of 49 cases of invasive pulmonary aspergillosis]

A clinical studv of 49 cases of invasive pulmonary aspergillosis

Clinical Manifestations and Imaging Findings of Patients with Invasive Pulmonary Aspergillosis

Invasive Pulmonary Aspergillosis: 20 Cases

Fatal invasive pulmonary aspergillosis in non-immunocompromised host: A case report

Analysis of risk factors of mortality in interstitial pneumonia patients with invasive pulmonary aspergillosis

Diagnosis of Invasive Pulmonary Aspergillosis in the Intensive Care Unit: What We Should Concern and How to Do Better

Invasive Pulmonary Aspergillosis In Adults With Avian Influenza A (H7n9) Pneumonia In China: A Retrospective Study